Company requirements under Canada's Access to Medicines Regime (English, HTML)

View metadata and access the original English HTML file: Company requirements under Canada's Access to Medicines Regime.

Format

HTML

Access

file-only

Publisher-reported update

2020-09-17

To participate in the Regime, a pharmaceutical company must enter into a sales agreement with an eligible importing country for the purchase of a specified amount of an eligible product listed on Schedule 1. A pharmaceutical company must also submit an application for authorization to Canada's Commissioner of Patents. Once the authorization or compulsory licence is issued, there are additional terms and conditions that the company must meet and maintain.

Access original file